Stephen D. Houston

Egerton Road
Guildford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 17, 2018

Ancient lowland Maya complexity as revealed by airborne laser scanning of northern Guatemala.

Ancient lowland Maya complexity as revealed by airborne laser scanning of northern Guatemala.

Journal: Science (New York, N.Y.)

Published: May 02, 2018

Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.

Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 02, 2016

Flying After Conducting an Aircraft Excessive Cabin Leakage Test.

Flying After Conducting an Aircraft Excessive Cabin Leakage Test.

Journal: Aerospace medicine and human performance

Published: September 17, 2016

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.

Journal: Breast cancer research : BCR

Published: October 05, 2015

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.

Journal: The Lancet. Oncology

Published: May 16, 2015

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.

Journal: The Lancet. Oncology

Published: December 24, 2013

Commercial air travel after intraocular gas injection.

Commercial air travel after intraocular gas injection.

Journal: Aviation, space, and environmental medicine

Published: August 10, 2012

Fatigue reporting among aircrew: incidence rate and primary causes.

Fatigue reporting among aircrew: incidence rate and primary causes.

Journal: Aviation, space, and environmental medicine

Published: August 10, 2012

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab.

Journal: Breast cancer research and treatment

Published: February 15, 2012

Prevalence of cardiovascular disease risk factors among UK commercial pilots.

Prevalence of cardiovascular disease risk factors among UK commercial pilots.

Journal: European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology

Published: April 01, 2011

Application of a cardiovascular disease risk prediction model among commercial pilots.

Application of a cardiovascular disease risk prediction model among commercial pilots.

Journal: Aviation, space, and environmental medicine

Published: August 05, 2010

Showing 1-12 of 12

Last Updated: 09/26/2026